{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T18:56:12Z","timestamp":1778439372946,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/ki.2013.501","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T13:51:18Z","timestamp":1389793878000},"page":"1137-1150","source":"Crossref","is-referenced-by-count":28,"title":["Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1 -deficient mice"],"prefix":"10.1016","volume":"85","author":[{"given":"Jonathan M.","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andressa G.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauri F.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro E.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Piontek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Irigoyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry J.","family":"Watnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz F.","family":"Onuchic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.501_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ajkd.2007.10.037","article-title":"Variation in age at ESRD in autosomal dominant polycystic kidney disease","volume":"51","author":"Reed","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.501_bb0020","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.501_bb0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.01581105","article-title":"Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years","volume":"1","author":"Dicks","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","article-title":"Extrarenal manifestations of autosomal dominant polycystic kidney disease","volume":"17","author":"Pirson","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2013.501_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2013.501_bb0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.amjhyper.2004.06.020","article-title":"Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population","volume":"17","author":"Kelleher","year":"2004","journal-title":"Am. J. Hypertens"},{"key":"10.1038\/ki.2013.501_bb0050","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/j.1523-1755.2005.00682.x","article-title":"Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease","volume":"68","author":"Oflaz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0055","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2013.501_bb0065","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ki.1972.78","article-title":"Adult polycystic kidney disease: studies of the defect in urine concentration","volume":"2","author":"Martinez-Maldonado","year":"1972","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0075","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0080","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","article-title":"Vasopressin antagonists in polycystic kidney disease","volume":"68","author":"Torres","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.0954-6820.1986.tb03276.x","article-title":"Exaggerated natriuresis in adult polycystic kidney disease","volume":"219","author":"Danielsen","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1038\/ki.2013.501_bb0090","first-page":"329","article-title":"The effect of hypervolemia on electrolyte level and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease","volume":"96","author":"Michalski","year":"1996","journal-title":"Pol Arch Med Wewn"},{"key":"10.1038\/ki.2013.501_bb0095","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/ki.2013.501_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2013.501_bb0105","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","article-title":"A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo","volume":"15","author":"Piontek","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0115","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1681\/ASN.2008040435","article-title":"Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion","volume":"20","author":"Bastos","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","article-title":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease","volume":"59","author":"Kobori","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1038\/ki.2013.501_bb0125","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1097-2765(00)00123-4","article-title":"Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells","volume":"6","author":"Boletta","year":"2000","journal-title":"Mol Cell"},{"key":"10.1038\/ki.2013.501_bb0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1172\/JCI0212867","article-title":"The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells","volume":"109","author":"Nickel","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2013.501_bb0135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1681\/ASN.2010010127","article-title":"Aberrant regulation of planar cell polarity in polycystic kidney disease","volume":"21","author":"Luyten","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrneph.2011.196","article-title":"Polycystic kidney disease in 2011: connecting the dots toward a polycystic kidney disease therapy","volume":"8","author":"Torres","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2013.501_bb0145","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.501_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1152\/ajprenal.00370.2003","article-title":"The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease","volume":"287","author":"Loghman-Adham","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2013.501_bb0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ki.1992.297","article-title":"Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease","volume":"42","author":"Torres","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0160","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.1988.115","article-title":"The anatomy of the renin-secreting cell in adult polycystic kidney disease","volume":"33","author":"Graham","year":"1988","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.501_bb0165","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.501_bb0170","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","article-title":"The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients","volume":"24","author":"Doulton","year":"2006","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2013.501_bb0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000166929","article-title":"Hypertension of polycystic kidney disease: mechanisms and hemodynamic alterations","volume":"5","author":"Valvo","year":"1985","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2013.501_bb0180","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","article-title":"Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Wang","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.501_bb0190","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/hmg\/11.15.1731","article-title":"Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant","volume":"11","author":"Muto","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1038\/ki.2013.501_bb0195","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol Res"},{"key":"10.1038\/ki.2013.501_bb0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"5 Pt 2","key":"10.1038\/ki.2013.501_bb0205","first-page":"R1420","article-title":"Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure","volume":"275","author":"Cowley","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2013.501_bb0210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/hy1001.092641","article-title":"Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung","volume":"38","author":"Nicco","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2013.501_bb0215","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2005101032","article-title":"Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes","volume":"17","author":"Chen","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0220","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1681\/ASN.2007101139","article-title":"Pkd1 inactivation induced in adulthood produces focal cystic disease","volume":"19","author":"Takakura","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.501_bb0225","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0960-9822(02)70717-3","article-title":"Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination","volume":"6","author":"Betz","year":"1996","journal-title":"Curr Biol"},{"key":"10.1038\/ki.2013.501_bb0230","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1681.2009.05330.x","article-title":"Ace gene dosage influences the development of renovascular hypertension","volume":"37","author":"Ceroni","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381556328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381556328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T17:02:12Z","timestamp":1648054932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381556328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S008525381556328X"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.501","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}